1.60 Zydus Lifesciences concludes subject enrolment in Phase II ALS trial

<< vissza

Zydus Lifesciences concludes subject enrolment in Phase II ALS trial
Dátum: 2024-05-24 [news.yahoo.com]

A TELJES HÍR ELOLVASÁSA >>
×